Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:RNLX

Renalytix (RNLX) Stock Price, News & Analysis

Renalytix logo

About Renalytix Stock (NASDAQ:RNLX)

Advanced Chart

Key Stats

Today's Range
$0.19
$0.23
50-Day Range
$0.18
$0.30
52-Week Range
$0.18
$2.40
Volume
934,496 shs
Average Volume
1.45 million shs
Market Capitalization
$17.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RNLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Renalytix and its competitors with MarketBeat's FREE daily newsletter.

RNLX Stock News Headlines

Renalytix Adjusts Share Capital Amid Fundraising Shortfall
The Coin That Could Define Trump’s Crypto Presidency
When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”
See More Headlines

RNLX Stock Analysis - Frequently Asked Questions

Renalytix Plc (NASDAQ:RNLX) posted its quarterly earnings data on Tuesday, November, 14th. The company reported ($0.11) EPS for the quarter, hitting analysts' consensus estimates of ($0.11). The business had revenue of $0.46 million for the quarter, compared to analyst estimates of $0.70 million.

Renalytix (RNLX) raised $156 million in an initial public offering on Friday, July 17th 2020. The company issued 11,000,000 shares at a price of $14.22 per share. J.P. Morgan and Stifel served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Renalytix investors own include Invesco QQQ (QQQ), SPDR Dow Jones Industrial Average ETF Trust (DIA), SPDR S&P 500 ETF Trust (SPY), NVIDIA (NVDA), CrowdStrike (CRWD), Broadcom (AVGO) and Meta Platforms (META).

Company Calendar

Last Earnings
11/14/2023
Today
8/10/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Medical laboratories
Sub-Industry
Healthcare
Current Symbol
NASDAQ:RNLX
CIK
1811115
Fax
N/A
Employees
100
Year Founded
2018

Profitability

EPS (Trailing Twelve Months)
($0.39)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$33.46 million
Net Margins
-1,461.60%
Pretax Margin
-1,461.42%
Return on Equity
N/A
Return on Assets
-281.40%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.53
Quick Ratio
0.53

Sales & Book Value

Annual Sales
$2.29 million
Price / Sales
7.50
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.10) per share
Price / Book
-2.07

Miscellaneous

Outstanding Shares
82,960,000
Free Float
63,059,000
Market Cap
$17.18 million
Optionable
Optionable
Beta
2.72

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:RNLX) was last updated on 8/11/2025 by MarketBeat.com Staff
From Our Partners